Login / Signup

AFX unibody stent graft: Effective and safe for the treatment of severe aorto-iliac occlusive disease.

Erin Cihat SaricilarJustin CainCindy WangCharles FisherVikram Puttaswamy
Published in: Vascular (2023)
Primary, assisted primary and secondary patency rates of AFX stent-grafts, when used to treat aorto-iliac occlusive disease, are high. This study supports the use of the AFX stent-graft for the endovascular treatment of complex aorto-iliac occlusive disease as an alternative to other endovascular options as well as a safe alternative to open aorto-iliac or aorto-femoral bypass in patients who are at high risk for open procedures.
Keyphrases
  • endovascular treatment
  • end stage renal disease
  • sickle cell disease
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes